EU approves two sites for making Pfizer's COVID-19 vaccine
Meanwhile, the European Union's medicines regulator has started evaluating the use of Pfizer Inc and BioNTech's COVID-19 vaccine in children between the ages of five and 11.
By Reuters | Updated:
AFP
Europe's drug regulator said on Monday it has approved two more manufacturing sites for producing the COVID-19 vaccine developed by Pfizer Inc
Download
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
Related Articles
Pfizer CFO Dave Denton to leave company in AugustADVERTISEMENT
